A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa (MEASUREAAVitHS)

AbbVie

Status: Enrolling

Conditions: Hidradenitis Suppurativa; Non-Segmental Vitiligo (NSV); Alopecia Areata

Study type: Observational

Funder types: Industry

Identifiers

NCT07136467

H25-663

Details and patient eligibility

About

This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.

Enrollment: 2,795 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS)
• Participants Ability to understand study questionnaires, with caregiver support as required for adolescents

Exclusion criteria

• Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study)
• Unable or unwilling to comply with study requirements and PRO collection

Trial design

2,795 participants in 3 patient groups

Participants with Vitiligo

Description:

Participants with vitiligo will undergo a single-visit data collection per routine clinical practice

Participants with Alopecia Areata

Description:

Participants with alopecia areata will undergo a single-visit data collection per routine clinical practice

Participants with Hidradenitis Suppurativa

Description:

Participants with hidradenitis suppurativa will undergo a single-visit data collection per routine clinical practice